Atlas Trials

Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma

Clinical trial NCT01283048 · COMPLETED

Trial details

NCT number
NCT01283048
Sponsor
Toni Choueiri, MD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2011-09-01
Primary completion
2016-09-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.